A Dose-escalation Study of LPM3480392 in Chinese Healthy Subjects

NCT05862974 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LPM3480392
DRUG: Placebo

Sponsor

Luye Pharma Group Ltd.